Ocular Therapeutix’ investigational therapy, AXPAXLI™ (also known as OTX-TKI), is an axitinib hydrogel administered by intravitreal injection that has the potential to dramatically improve durability ...

Registration is closed but tickets will be available on site. Please contact Sarah Ungerer at [email protected] for more information. Join PSBJ for our 14th Annual CFO of the Year Awards!